Abstract
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by intestinal L cells whose primary function involves the maintenance of glycemic homeostasis. However, different studies have consistently demonstrated that GLP-1 receptor (GLP-1R) agonists, drugs used to treat type 2 diabetes mellitus, exert several extraglycemic effects, including increased diuresis and natriuresis and red…